Non-Specific Interstitial Pneumonia in a Woman with Osteoporosis Treated with Denosumab

Denosumab and Lung Complications: A Rare Case of Non-Specific Interstitial Pneumonia

💡 Did you know? A recent case report highlights a rare but serious lung complication associated with Denosumab, a widely used osteoporosis treatment.

🔬 Published in the Journal of Biomedical Research & Environmental Sciences (JBRES), this case study discusses the development of Non-Specific Interstitial Pneumonia (NSIP) in a woman undergoing Denosumab therapy. The patient presented with respiratory distress, lung inflammation, and reduced lung function, leading to an unexpected diagnosis of NSIP.

📖 Read the full article here:
🔗 Non-Specific Interstitial Pneumonia in a Woman with Osteoporosis Treated with Denosumab

🔍 Key Takeaways from the Study:

✅ Denosumab and NSIP Connection – A rare case of lung complications linked to osteoporosis treatment.
✅ Early Symptoms Matter – Dry cough, shortness of breath, and fatigue could be warning signs.
✅ Timely Drug Discontinuation – The patient showed improvement after stopping Denosumab and receiving corticosteroid treatment.
✅ Need for Further Research – Understanding immune modulation by Denosumab and its long-term effects.

Are you conducting groundbreaking research in medicine, pulmonology, or biomedical sciences? 📑 We invite researchers, scientists, and medical professionals to submit their manuscripts for our upcoming issues!

✔ Fast-track peer review (7-14 days to publication)
✔ Indexed in IndexCopernicus, Google Scholar, and more
✔ Affordable APC discounts available for early submissions
✔ Open access for global visibility

📝 Submit your manuscript today!
📌 Submission Link: https://www.jelsciences.com/submit-form.php
📧 Email us at: lisaarya.srl@gmail.com
📱 Chat with us on WhatsApp and LiveChat